U.S. Women’s Health Market Size, Share & Trends Analysis Report By Application (Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis), By Age, By Drug, By Distribution Channel, And Segment Forecasts, 2023 - 2030

Market Segmentation

• U.S. Women’s Health Drug Outlook (Revenue, USD Million, 2018 - 2030)
• ACTONEL
• YAZ, Yasmin, Yasminelle
• FORTEO
• Minastrin 24 Fe
• Mirena
• NuvaRing
• ORTHO TRI-CY LO
• Premarin
• Prolia
• Reclast/Aclasta
• XGEVA
• Zometa
• Others
• U.S. Women’s Health Application Outlook (Revenue, USD Million, 2018 - 2030)
• Hormonal Infertility
• Contraceptives
• Postmenopausal Osteoporosis
• Endometriosis & Uterine Fibroids
• Menopause
• Polycystic Ovary Syndrome (PCOS)
• U.S. Women’s Health Age Outlook (Revenue, USD Million, 2018 - 2030)
• 50 years and above
  • Postmenopausal Osteoporosis
  • Endometriosis & Uterine Fibroids
  • Menopause
  • Others
• Others
• U.S. Women’s Health Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
• Hospital Pharmacy
• Retail Pharmacy

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance